Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

Over 200 visitors interacted with each other over themes of drug resistant tuberculosis, extra-pulmonary TB and developments ...

According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

THURSDAY, Feb. 6, 2025 (HealthDay News) -- Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-susceptible, rifampin-resistant tuberculosis, ...

These receptors do not seem to have mechanisms of ligand-induced downregulation and exhibit rapid clearance of the ligand-bound drug ... resistant strains to antibiotics. No new anti-TB agents ...

Objectives: To provide valuable insights for targeted interventions and resource allocation, our analysis delved into the multifaceted burden, trends, risks, and projections of multi drug resistant ...

Background The quality of care for patients with TB in Eastern Europe has improved significantly; nevertheless drug resistance rates remain high. We analysed survival in a cohort of patients with ...

Hundreds of people in New Jersey, Delaware, and Pennsylvania are sickened with TB every year, but a recent deadly outbreak in Kansas has some worried about the disease’s spread. Tuberculosis ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

Health officials are raising the alarm over a large and ongoing tuberculosis (TB ... if any of the cases in the current outbreak are drug-resistant but did not receive a response by the time ...